184 related articles for article (PubMed ID: 29899121)
21. Aurora kinase A in gastrointestinal cancers: time to target.
Katsha A; Belkhiri A; Goff L; El-Rifai W
Mol Cancer; 2015 May; 14():106. PubMed ID: 25987188
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of mitotic Aurora kinase A by alisertib induces apoptosis and autophagy of human gastric cancer AGS and NCI-N78 cells.
Yuan CX; Zhou ZW; Yang YX; He ZX; Zhang X; Wang D; Yang T; Wang NJ; Zhao RJ; Zhou SF
Drug Des Devel Ther; 2015; 9():487-508. PubMed ID: 25609923
[TBL] [Abstract][Full Text] [Related]
23. Optimized FRET Pairs and Quantification Approaches To Detect the Activation of Aurora Kinase A at Mitosis.
Bertolin G; Sizaire F; Déméautis C; Chapuis C; Mérola F; Erard M; Tramier M
ACS Sens; 2019 Aug; 4(8):2018-2027. PubMed ID: 31317736
[TBL] [Abstract][Full Text] [Related]
24. Natural anthraquinone compound emodin as a novel inhibitor of aurora A kinase: A pilot study.
Wu FL; Chu PY; Chen GY; Wang K; Hsu WY; Ahmed A; Ma WL; Cheng WC; Wu YC; Yang JC
Chem Biol Drug Des; 2022 Jan; 99(1):126-135. PubMed ID: 34411446
[TBL] [Abstract][Full Text] [Related]
25. FOXM1 recruits nuclear Aurora kinase A to participate in a positive feedback loop essential for the self-renewal of breast cancer stem cells.
Yang N; Wang C; Wang Z; Zona S; Lin SX; Wang X; Yan M; Zheng FM; Li SS; Xu B; Bella L; Yong JS; Lam EW; Liu Q
Oncogene; 2017 Jun; 36(24):3428-3440. PubMed ID: 28114286
[TBL] [Abstract][Full Text] [Related]
26. AurkA nuclear localization is promoted by TPX2 and counteracted by protein degradation.
Asteriti IA; Polverino F; Stagni V; Sterbini V; Ascanelli C; Naso FD; Mastrangelo A; Rosa A; Paiardini A; Lindon C; Guarguaglini G
Life Sci Alliance; 2023 May; 6(5):. PubMed ID: 36797043
[TBL] [Abstract][Full Text] [Related]
27. Aurora Kinase A is critical for the Nkx6.1 mediated β-cell proliferation pathway.
Hobson A; Draney C; Stratford A; Becker TC; Lu D; Arlotto M; Tessem JS
Islets; 2015; 7(1):e1027854. PubMed ID: 26030060
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of AURKA Reduces Proliferation and Survival of Gastrointestinal Cancer Cells With Activated KRAS by Preventing Activation of RPS6KB1.
Wang-Bishop L; Chen Z; Gomaa A; Lockhart AC; Salaria S; Wang J; Lewis KB; Ecsedy J; Washington K; Beauchamp RD; El-Rifai W
Gastroenterology; 2019 Feb; 156(3):662-675.e7. PubMed ID: 30342037
[TBL] [Abstract][Full Text] [Related]
29. Combined inhibition of Aurora A and p21-activated kinase 1 as a new treatment strategy in breast cancer.
Korobeynikov V; Borakove M; Feng Y; Wuest WM; Koval AB; Nikonova AS; Serebriiskii I; Chernoff J; Borges VF; Golemis EA; Shagisultanova E
Breast Cancer Res Treat; 2019 Sep; 177(2):369-382. PubMed ID: 31254157
[TBL] [Abstract][Full Text] [Related]
30. Aurora Kinase A proximity map reveals centriolar satellites as regulators of its ciliary function.
Arslanhan MD; Rauniyar N; Yates JR; Firat-Karalar EN
EMBO Rep; 2021 Aug; 22(8):e51902. PubMed ID: 34169630
[TBL] [Abstract][Full Text] [Related]
31. Silencing Aurora-A with siRNA inhibits cell proliferation in human lung adenocarcinoma cells.
Zhong N; Shi S; Wang H; Wu G; Wang Y; Ma Q; Wang H; Liu Y; Wang J
Int J Oncol; 2016 Sep; 49(3):1028-38. PubMed ID: 27571708
[TBL] [Abstract][Full Text] [Related]
32. Alisertib, an Aurora kinase A inhibitor, induces apoptosis and autophagy but inhibits epithelial to mesenchymal transition in human epithelial ovarian cancer cells.
Ding YH; Zhou ZW; Ha CF; Zhang XY; Pan ST; He ZX; Edelman JL; Wang D; Yang YX; Zhang X; Duan W; Yang T; Qiu JX; Zhou SF
Drug Des Devel Ther; 2015; 9():425-64. PubMed ID: 25624750
[TBL] [Abstract][Full Text] [Related]
33. Silencing Aurora-kinase-A (AURKA) reinforced the sensitivity of diffuse large B-cell lymphoma cells to cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) via suppressing β-Catenin and RAS-extracellular signal-regulated protein kinase (ERK1/2) pathway.
Wang S; Sun L
Bioengineered; 2021 Dec; 12(1):8296-8308. PubMed ID: 34565287
[TBL] [Abstract][Full Text] [Related]
34. Targeting Aurora kinase A suppresses the growth of human oral squamous cell carcinoma cells in vitro and in vivo.
Tanaka H; Nakashiro K; Iwamoto K; Tokuzen N; Fujita Y; Shirakawa R; Oka R; Goda H; Hamakawa H
Oral Oncol; 2013 Jun; 49(6):551-9. PubMed ID: 23481312
[TBL] [Abstract][Full Text] [Related]
35. Activation of EIF4E by Aurora Kinase A Depicts a Novel Druggable Axis in Everolimus-Resistant Cancer Cells.
Katsha A; Wang L; Arras J; Omar OM; Ecsedy J; Belkhiri A; El-Rifai W
Clin Cancer Res; 2017 Jul; 23(14):3756-3768. PubMed ID: 28073841
[No Abstract] [Full Text] [Related]
36. Effects of AURKA-mediated degradation of SOD2 on mitochondrial dysfunction and cartilage homeostasis in osteoarthritis.
Yang C; You D; Huang J; Yang B; Huang X; Ni J
J Cell Physiol; 2019 Aug; 234(10):17727-17738. PubMed ID: 30811038
[TBL] [Abstract][Full Text] [Related]
37. Overcoming MITF-conferred drug resistance through dual AURKA/MAPK targeting in human melanoma cells.
Pathria G; Garg B; Borgdorff V; Garg K; Wagner C; Superti-Furga G; Wagner SN
Cell Death Dis; 2016 Mar; 7(3):e2135. PubMed ID: 26962685
[TBL] [Abstract][Full Text] [Related]
38. Increased AURKA promotes cell proliferation and predicts poor prognosis in bladder cancer.
Guo M; Lu S; Huang H; Wang Y; Yang MQ; Yang Y; Fan Z; Jiang B; Deng Y
BMC Syst Biol; 2018 Dec; 12(Suppl 7):118. PubMed ID: 30547784
[TBL] [Abstract][Full Text] [Related]
39. Hyper-activation of Aurora kinase a-polo-like kinase 1-FOXM1 axis promotes chronic myeloid leukemia resistance to tyrosine kinase inhibitors.
Mancini M; De Santis S; Monaldi C; Bavaro L; Martelli M; Castagnetti F; Gugliotta G; Rosti G; Santucci MA; Martinelli G; Cavo M; Soverini S
J Exp Clin Cancer Res; 2019 May; 38(1):216. PubMed ID: 31122263
[TBL] [Abstract][Full Text] [Related]
40. Allosteric Targeting of Aurora A Kinase Using Small Molecules: A Step Forward Towards Next Generation Medicines?
Panicker RC; Coyne AG; Srinivasan R
Curr Med Chem; 2019; 26(13):2234-2242. PubMed ID: 28748768
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
